Long-term outcomes in simultaneous kidney-pancreas transplant recipients with portal-enteric versus systemic-bladder drainage.
Lo
A
A
Department of Pharmacy, University of Tennessee-Memphis, Memphis, Tennessee, USA.
Stratta
R J
RJ
Hathaway
D K
DK
Egidi
M F
MF
Shokouh-Amiri
M H
MH
Grewal
H P
HP
Winsett
R
R
Trofe
J
J
Alloway
R R
RR
Gaber
A O
AO
D000328:Adult; D005260:Female; D005500:Follow-Up Studies; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007422:Intestines / Q000601:surgery*; D016030:Kidney Transplantation / Q000276:immunology / Q000379:methods* / Q000401:mortality; D008297:Male; D016035:Pancreas Transplantation / Q000276:immunology / Q000379:methods* / Q000401:mortality; D010359:Patient Readmission / Q000706:statistics & numerical data; D011168:Portal System / Q000601:surgery*; D015996:Survival Rate; D013997:Time Factors; D016896:Treatment Outcome; D001743:Urinary Bladder / Q000601:surgery*
D007166:Immunosuppressive Agents